Thomas Eschenhagen - Selected Publications#

Total 277 PubMed-listed publications, 11,247 citations (SciVal), h-index 59

1. Eschenhagen T, Fink C, Remmers U, Scholz H, Wattchow J, Weil J, Zimmermann WH, Dohmen HH, Schäfer H, Bishopric N, Wakatsuki T, Elson EL (1997) Three dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J 11:683-694, first cardiac tissue engineering paper, 331 citations

2. Vandecasteele G*, Eschenhagen T*, Scholz H, Stein B, Verde I, Fischmeister F (1999) Muscarinic and -adrenergic regulation of heart rate, force of contraction and Ca2+ current is preserved in mice lacking endothelial nitric oxide synthase. Nat Med 5: 331-334 (*split first autorship), 132 citations

3. Zimmermann WH, Scheiderbanger K, Schubert P, Didie M, Münzel F, Heubach JF, Kostin S, Neuhuber WL, Eschenhagen T (2002) Tissue engineering of a differentiated cardiac muscle construct. Circ Res 90: 223-230, 512 citations

4. Lohse MJ, Engelhardt S, Eschenhagen T (2003) What is the role of beta-adrenergic signalling in heart failure. Circ Res 93: 896-906, 399 citations

5. Eschenhagen T, Zimmermann WH (2005) Engineering myocardial tissue. Circ Res 97: 1220-1231, 178 citations

6. Rau T, Wohlleben G, Wuttke H, Thuerauf N, Lunkenheimer J, Lanczik M, Eschenhagen T (2004) CYP2D6 genotype: Impact on adverse effects and nonresponse during treatment with antidepressants - a pilot study. Clin Pharmacol Ther 75: 386-393, 160 citations

7. Zimmermann WH, Melnychenko I, Wasmeier G, Didie M, Naito H, Nixdorf U, Hess A, Budinsky L, Brune K, Michaelis B, Dhein S, Schwoerer A, Ehmke H, Eschenhagen T (2006) Engineered heart tissue grafts improve systolic function and prevent deterioration of diastolic function in infarcted rat hearts. Nat Med 12: 452-458, 530 citations

8. Wittköpper K, Fabritz L, Neef S, Ort KR, Grefe C, Unsöld B, Kirchhof B, Maier LS, Hasenfuss G, Dobrev D, Eschenhagen T*, El-Armouche A* (2010) Constitutively active phosphatase inhibitor-1 improves cardiac contractility in young mice but is deleterious after catecholaminergic stress and with ageing. J Clin Invest 120: 617-626 (split last authorship), 63 citations

9. Hansen A, Eder A, Börnstrup M, Flato M, Mewe M, Schaaf S, Aksehirlioglu B, Schwörer A, Uebeler J, Eschenhagen T (2010) Development of a drug screening platform based on engineered heart tissue. Circ Res 107: 35-44, 164 citations

10. Weinberger F, Brechwoldt K, Pecha S, Kelly A, Geertz B, Starbatty J, Yorgan T, Cheng KH, Lessmann K, Stolen T, Scherrer-Crosbie M, Smith G, Reichenspurner H, Hansen A, Eschenhagen T (2016) Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells. Sci Translat Med 8: 363ra146, 8 citations